Unbound MEDLINE

risedronate journal articles from PubMed MEDLINE database

Unbound MEDLINE results for:RSS FEEDBookmark this site
risedronate| Refine this search
1 - 10 of 1093 journal articles in the PubMed databaseEmail to a friend    
 
Kwon YD, Kim DY, Ohe JY, et al. 
Correlation Between Serum C-Terminal Cross-Linking Telopeptide of Type I Collagen and Staging of Oral Bisphosphonate-Related Osteonecrosis of the Jaws. [JOURNAL ARTICLE]
J Oral Maxillofac Surg 2009 Dec; 67(12):2644-2648.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Gourion-Arsiquaud S, Allen MR, Burr DB, et al. 
Bisphosphonate Treatment Modifies Canine Bone Mineral and Matrix Properties and their Heterogeneity. [JOURNAL ARTICLE]
Bone 2009 Nov 16.
Abstract | Full Citation
Lawson MA, Xia Z, Barnett BL, et al. 
Differences between bisphosphonates in binding affinities for hydroxyapatite. [JOURNAL ARTICLE]
J Biomed Mater Res B Appl Biomater 2009 Nov 10.
Abstract | Full Citation | Find Related Articles 
Devold HM, Doung GM, Tverdal A, et al. 
Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway. [JOURNAL ARTICLE]
Eur J Clin Pharmacol 2009 Nov 7.
Abstract | Full Citation | Find Related Articles 
Thompson M, Pasquale M, Grima D, et al. 
The Impact of Fewer Hip Fractures with Risedronate Versus Alendronate in the First Year of Treatment: Modeled German Cost-Effectiveness Analysis. [JOURNAL ARTICLE]
Value Health 2009 Oct 26.
Abstract | Full Citation | Find Related Articles 
Vestergaard P, Schwartz K, Pinholt EM, et al. 
Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism. [JOURNAL ARTICLE]
Osteoporos Int 2009 Oct 27.
Abstract | Full Citation | Find Related Articles 
Feher A, Koivunemi A, Koivunemi M, et al. 
Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading. [JOURNAL ARTICLE]
Bone 2009 Oct 23.
Abstract | Full Citation
van Londen GJ, Perera S, Vujevich KT, et al. 
The Effect of Risedronate on Hip Structural Geometry in Chemotherapy-Induced Postmenopausal Women on SERMs versus Aromatase Inhibitors: a Two Year Trial. [JOURNAL ARTICLE]
Bone 2009 Oct 21.
Abstract | Full Citation | Find Related Articles 
Boonen S, Kay R, Cooper C, et al. 
Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases. [JOURNAL ARTICLE]
Int J Clin Pract 2009 Oct 20.
Abstract | Full Citation | Find Related Articles 
Epstein S, Jeglitsch M, McCloskey E 
Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Oct 16.
Abstract | Full Citation | Find Related Articles 
New Search Next Results
  

Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo


Advertise on this site.